Your browser doesn't support javascript.
loading
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis.
Li, Gang; Zheng, Tian-Lei; Chi, Xiao-Ling; Zhu, Yong-Fen; Chen, Jin-Jun; Xu, Liang; Shi, Jun-Ping; Wang, Xiao-Dong; Zhao, Wei-Guo; Byrne, Christopher D; Targher, Giovanni; Rios, Rafael S; Huang, Ou-Yang; Tang, Liang-Jie; Zhang, Shi-Jin; Geng, Shi; Xiao, Huan-Ming; Chen, Sui-Dan; Zhang, Rui; Zheng, Ming-Hua.
  • Li G; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zheng TL; Artificial Intelligence Unit, Department of Medical Equipment, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Chi XL; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhu YF; Department of Hepatology and Infection, Sir Run Run Shaw Hospital, Affiliated with School of Medicine, Zhejiang University, Hangzhou, China.
  • Chen JJ; Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xu L; Hepatology Unit, Zengcheng Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Shi JP; Department of Hepatology, Tianjin Second People's Hospital, Tianjin, China.
  • Wang XD; Department of Liver Diseases, Hangzhou Normal University Affiliated Hospital, Hangzhou, China.
  • Zhao WG; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China.
  • Byrne CD; Artificial Intelligence Unit, Department of Medical Equipment, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Targher G; Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton & University of Southampton, Southampton General Hospital, Southampton, UK.
  • Rios RS; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy.
  • Huang OY; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Tang LJ; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zhang SJ; MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Geng S; Artificial Intelligence Unit, Department of Medical Equipment, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Xiao HM; Artificial Intelligence Unit, Department of Medical Equipment, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Chen SD; Department of Hepatology, Guangdong Provincial Hospital of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhang R; Department of Pathology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Zheng MH; Department of Nutrition, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Hepatobiliary Surg Nutr ; 12(4): 507-522, 2023 Aug 01.
Article en En | MEDLINE | ID: mdl-37600991
ABSTRACT

Background:

There is an unmet need for accurate non-invasive methods to diagnose non-alcoholic steatohepatitis (NASH). Since impedance-based measurements of body composition are simple, repeatable and have a strong association with non-alcoholic fatty liver disease (NAFLD) severity, we aimed to develop a novel and fully automatic machine learning algorithm, consisting of a deep neural network based on impedance-based measurements of body composition to identify NASH [the bioeLectrical impEdance Analysis foR Nash (LEARN) algorithm].

Methods:

A total of 1,259 consecutive subjects with suspected NAFLD were screened from six medical centers across China, of which 766 patients with biopsy-proven NAFLD were included in final analysis. These patients were randomly subdivided into the training and validation groups, in a ratio of 41. The LEARN algorithm was developed in the training group to identify NASH, and subsequently, tested in the validation group.

Results:

The LEARN algorithm utilizing impedance-based measurements of body composition along with age, sex, pre-existing hypertension and diabetes, was able to predict the likelihood of having NASH. This algorithm showed good discriminatory ability for identifying NASH in both the training and validation groups [area under the receiver operating characteristics (AUROC) 0.81, 95% CI 0.77-0.84 and AUROC 0.80, 95% CI 0.73-0.87, respectively]. This algorithm also performed better than serum cytokeratin-18 neoepitope M30 (CK-18 M30) level or other non-invasive NASH scores (including HAIR, ION, NICE) for identifying NASH (P value <0.001). Additionally, the LEARN algorithm performed well in identifying NASH in different patient subgroups, as well as in subjects with partial missing body composition data.

Conclusions:

The LEARN algorithm, utilizing simple easily obtained measures, provides a fully automated, simple, non-invasive method for identifying NASH.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article